Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-24
DOI
10.3389/fnagi.2019.00088
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulin is a potential antioxidant for diabetes-associated cognitive decline via regulating Nrf2 dependent antioxidant enzymes
- (2018) Ying Song et al. BIOMEDICINE & PHARMACOTHERAPY
- Monocytes as immune targets in arterial hypertension
- (2018) Philip Wenzel BRITISH JOURNAL OF PHARMACOLOGY
- Sustained high-fat diet modulates inflammation, insulin signalling and cognition in mice and a modified xenin peptide ameliorates neuropathology in a chronic high-fat model
- (2018) Paul Denver et al. DIABETES OBESITY & METABOLISM
- Post-treatment with the GLP-1 analogue liraglutide alleviate chronic inflammation and mitochondrial stress induced by Status epilepticus
- (2018) Rui-Fang Wang et al. EPILEPSY RESEARCH
- Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders
- (2018) Mahip K. Verma et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
- (2018) Andre F Batista et al. JOURNAL OF PATHOLOGY
- Could Alzheimer’s Disease Originate in the Periphery and If So How So?
- (2018) Gerwyn Morris et al. MOLECULAR NEUROBIOLOGY
- Contributions of neurotropic human herpesviruses herpes simplex virus 1 and human herpesvirus 6 to neurodegenerative disease pathology
- (2018) Margot Mayer-Proschel et al. Neural Regeneration Research
- Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus
- (2018) Ben Readhead et al. NEURON
- Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
- (2018) Alwena H. Morgan et al. NEUROPHARMACOLOGY
- Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer's and Parkinson's disease models
- (2018) Christian Hölscher NEUROPHARMACOLOGY
- Leptin and ghrelin: Sewing metabolism onto neurodegeneration
- (2018) Paola de Candia et al. NEUROPHARMACOLOGY
- Insulin-mediated synaptic plasticity in the CNS: Anatomical, functional and temporal contexts
- (2018) Carrie R. Ferrario et al. NEUROPHARMACOLOGY
- GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes
- (2018) Victor A. Gault et al. PEPTIDES
- Neuroinflammation as a Target for Intervention in Subarachnoid Hemorrhage
- (2018) Airton Leonardo de Oliveira Manoel et al. Frontiers in Neurology
- Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases
- (2018) I A Clark et al. BRITISH JOURNAL OF PHARMACOLOGY
- Leptin Induces Proliferation of Neuronal Progenitors and Neuroprotection in a Mouse Model of Alzheimer's Disease
- (2018) Rocío Pérez-González et al. JOURNAL OF ALZHEIMERS DISEASE
- TNF and Leptin Tell Essentially the Same Story in Alzheimer's Disease
- (2018) Ian A. Clark et al. JOURNAL OF ALZHEIMERS DISEASE
- Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
- (2018) Chih-Cheng Hsu et al. JOURNAL OF ALZHEIMERS DISEASE
- Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease
- (2018) Amy Claxton et al. JOURNAL OF ALZHEIMERS DISEASE
- D-Ala2GIP Facilitated Synaptic Plasticity and Reduces Plaque Load in Aged Wild Type Mice and in an Alzheimer's Disease Mouse Model
- (2018) Emilie Faivre et al. JOURNAL OF ALZHEIMERS DISEASE
- Altered Serum Levels of Adipokines and Insulin in Probable Alzheimer's Disease
- (2018) Vineet Kumar Khemka et al. JOURNAL OF ALZHEIMERS DISEASE
- Stimulation of Insulin Signaling and Inhibition of JNK-AP1 Activation Protect Cells from Amyloid-β-Induced Signaling Dysregulation and Inflammatory Response
- (2018) Michelle Bamji-Mirza et al. JOURNAL OF ALZHEIMERS DISEASE
- Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
- (2018) Tze Pin Ng et al. JOURNAL OF ALZHEIMERS DISEASE
- Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural Diseases
- (2018) Hiroyuki Konishi et al. Frontiers in Cellular Neuroscience
- Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study
- (2018) Y. E. Lentferink et al. Nutrition & Diabetes
- Effect of D-Ala 2 GIP, a stable GIP receptor agonist on MPTP-induced neuronal impairments in mice
- (2017) Mahip K. Verma et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
- (2017) Yanwei Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
- (2017) Susanne Krasemann et al. IMMUNITY
- Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer’s Disease Biomarkers: A Pilot Clinical Trial
- (2017) Suzanne Craft et al. JOURNAL OF ALZHEIMERS DISEASE
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes
- (2017) Na Zhao et al. NEURON
- A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): Trial results and lessons learned
- (2017) PARKINSONISM & RELATED DISORDERS
- Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus
- (2017) Yi-Chun Kuan et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Microglia activation due to obesity programs metabolic failure leading to type two diabetes
- (2017) R Maldonado-Ruiz et al. Nutrition & Diabetes
- Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults
- (2017) Mark A. Reger et al. JOURNAL OF ALZHEIMERS DISEASE
- GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease
- (2017) Yazhou Li et al. JOURNAL OF ALZHEIMERS DISEASE
- Leptin Reduces Pathology and Improves Memory in a Transgenic Mouse Model of Alzheimer's Disease
- (2017) Steven J. Greco et al. JOURNAL OF ALZHEIMERS DISEASE
- Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells
- (2017) Theodora Panagaki et al. Scientific Reports
- Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology
- (2016) Adrian Olmos-Alonso et al. BRAIN
- The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy
- (2016) Henrik H. Hansen et al. BRAIN RESEARCH
- Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor
- (2016) V. Darsalia et al. DIABETES OBESITY & METABOLISM
- Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
- (2016) José A. Luchsinger et al. JOURNAL OF ALZHEIMERS DISEASE
- Acylated but not des-acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
- (2016) Jacqueline A. Bayliss et al. JOURNAL OF NEUROCHEMISTRY
- Microglial immunophenotype in dementia with Alzheimer’s pathology
- (2016) Thais Minett et al. Journal of Neuroinflammation
- Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease
- (2016) J. A. Bayliss et al. JOURNAL OF NEUROSCIENCE
- Neuroprotective role of (Val8) GLP-1-Glu-PAL in an in vitro model of Parkinson′s disease
- (2016) Yue-ze Liu et al. Neural Regeneration Research
- Neuroprotective effects of a GIP analogue in the MPTP Parkinson's disease mouse model
- (2016) Yanwei Li et al. NEUROPHARMACOLOGY
- Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer’s disease
- (2016) Chenhui Ji et al. REVIEWS IN THE NEUROSCIENCES
- Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases
- (2016) Yanwei Li et al. REVIEWS IN THE NEUROSCIENCES
- In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
- (2016) Michael Gejl et al. Frontiers in Aging Neuroscience
- The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia
- (2015) Panos Roussos et al. Alzheimers & Dementia
- Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice
- (2015) Paula L. McClean et al. BEHAVIOURAL BRAIN RESEARCH
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
- (2015) Celeste M. Karch et al. BIOLOGICAL PSYCHIATRY
- Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways
- (2015) Rania M. Abdelsalam et al. JOURNAL OF NEUROCHEMISTRY
- Neuronal LRP1 Regulates Glucose Metabolism and Insulin Signaling in the Brain
- (2015) C.-C. Liu et al. JOURNAL OF NEUROSCIENCE
- Is Alzheimer’s Disease Autoimmune Inflammation of the Brain That Can be Treated With Nasal Nonsteroidal Anti-Inflammatory Drugs?
- (2014) Steven Lehrer et al. American Journal of Alzheimers Disease and Other Dementias
- Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases
- (2014) Christian Hölscher BIOCHEMICAL SOCIETY TRANSACTIONS
- Leukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling
- (2014) Suidong Ouyang et al. BRAIN BEHAVIOR AND IMMUNITY
- The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration
- (2014) David Heras-Sandoval et al. CELLULAR SIGNALLING
- Coding variants in TREM2 increase risk for Alzheimer's disease
- (2014) Sheng Chih Jin et al. HUMAN MOLECULAR GENETICS
- More than Cholesterol Transporters: Lipoprotein Receptors in CNS Function and Neurodegeneration
- (2014) Courtney Lane-Donovan et al. NEURON
- Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease
- (2014) Paula L. McClean et al. NEUROPHARMACOLOGY
- Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice
- (2014) Rachael Lennox et al. NEUROPHARMACOLOGY
- Genetics of Alzheimer’s Disease
- (2014) Rita Guerreiro et al. Neurotherapeutics
- Insulin resistance, neuroinflammation, and Alzheimer’s disease
- (2014) Dema Najem et al. REVIEWS IN THE NEUROSCIENCES
- NIH will partner drug industry to study Alzheimer's, diabetes, and autoimmune disorders
- (2014) M. McCarthy BMJ-British Medical Journal
- Insulin in the Brain: Its Pathophysiological Implications for States Related with Central Insulin Resistance, Type 2 Diabetes and Alzheimer’s Disease
- (2014) Enrique Blázquez et al. Frontiers in Endocrinology
- TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer’s β-Amyloid Oligomers in Mice and Monkeys
- (2013) Mychael V. Lourenco et al. Cell Metabolism
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
- (2013) Jessica Freiherr et al. CNS DRUGS
- Anti-inflammatory cytokines and risk of type 2 diabetes
- (2013) C. Herder et al. DIABETES OBESITY & METABOLISM
- Lixisenatide: First Global Approval
- (2013) Shelley Elkinson et al. DRUGS
- Metreleptin: First Global Approval
- (2013) Ken Chou et al. DRUGS
- Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
- (2013) M E J Lean et al. INTERNATIONAL JOURNAL OF OBESITY
- Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance
- (2013) David J. Bonda et al. JOURNAL OF NEUROCHEMISTRY
- Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress
- (2013) Mohit K. Sharma et al. JOURNAL OF NEUROCHEMISTRY
- Emerging combinatorial hormone therapies for the treatment of obesity and T2DM
- (2013) Sharon A. Sadry et al. Nature Reviews Endocrinology
- Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease
- (2013) Jayasankar Kosaraju et al. NEUROPHARMACOLOGY
- Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
- (2013) Paula L. McClean et al. NEUROPHARMACOLOGY
- Combined Anti-Inflammatory and Anti-AGE Drug Treatments Have a Protective Effect on Intervertebral Discs in Mice with Diabetes
- (2013) Svenja Illien-Junger et al. PLoS One
- Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
- (2013) Emilie Faivre et al. Alzheimers Research & Therapy
- Leptin therapy in type 2 diabetes
- (2012) B. P. Cummings DIABETES OBESITY & METABOLISM
- Defining the Contribution of AMP-activated Protein Kinase (AMPK) and Protein Kinase C (PKC) in Regulation of Glucose Uptake by Metformin in Skeletal Muscle Cells
- (2012) Sophie Turban et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
- (2012) Theresa R. Bomfim et al. JOURNAL OF CLINICAL INVESTIGATION
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- Leptin-Induced mTOR Activation Defines a Specific Molecular and Transcriptional Signature Controlling CD4+ Effector T Cell Responses
- (2012) C. Procaccini et al. JOURNAL OF IMMUNOLOGY
- Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
- (2012) Patrick Imfeld et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Insulin resistance: An adaptive mechanism becomes maladaptive in the current environment — An evolutionary perspective
- (2012) Agathocles Tsatsoulis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- AMPK: a nutrient and energy sensor that maintains energy homeostasis
- (2012) D. Grahame Hardie et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease
- (2012) Caitriona M. Long-Smith et al. NEUROMOLECULAR MEDICINE
- The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer’s disease
- (2012) A.M. Duffy et al. NEUROSCIENCE
- The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
- (2011) Asger Lund et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Leptin in human physiology and pathophysiology
- (2011) Christos S. Mantzoros et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment
- (2011) Suzanne Craft ARCHIVES OF NEUROLOGY
- Pro-inflammatory cytokines intensify the activation of NO/NOS, JNK1/2 and caspase cascades in immature neurons exposed to elevated levels of unconjugated bilirubin
- (2011) Ana R. Vaz et al. EXPERIMENTAL NEUROLOGY
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
- (2011) P. L. McClean et al. JOURNAL OF NEUROSCIENCE
- Glucose tolerance status and risk of dementia in the community: The Hisayama Study
- (2011) T. Ohara et al. NEUROLOGY
- Inflammation and Alzheimer’s disease
- (2010) Young-Jung Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases
- (2010) Cláudia P. Figueiredo et al. BEHAVIOURAL PHARMACOLOGY
- Leptin Deficiency Causes Insulin Resistance Induced by Uncontrolled Diabetes
- (2010) J. P. German et al. DIABETES
- Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study
- (2010) E. M. C. Schrijvers et al. NEUROLOGY
- Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelin
- (2009) Rodolfo Gómez et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging
- (2009) Wolfgang Lieb JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Protease-Resistant Glucose-Dependent Insulinotropic Polypeptide Agonists Facilitate Hippocampal LTP and Reverse the Impairment of LTP Induced by Beta-Amyloid
- (2008) Victor A. Gault et al. JOURNAL OF NEUROPHYSIOLOGY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
- (2008) Aileen M. Moloney et al. NEUROBIOLOGY OF AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started